In vitro Assessment of Camphor Hydrazone Derivatives as an Agent Against Leishmania amazonensis
Purpose Due to serious problems with the treatment of leishmaniasis all around the world, here is an urgent need in the search for new drugs that are more effective and safer for the treatment of the various forms of leishmaniasis. Actual therapy is limited and lacks sufficient efficacy due to incom...
Gespeichert in:
Veröffentlicht in: | Acta parasitologica 2020-03, Vol.65 (1), p.203-207 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 207 |
---|---|
container_issue | 1 |
container_start_page | 203 |
container_title | Acta parasitologica |
container_volume | 65 |
creator | da Silva, Emerson Teixeira de Andrade, Gabriel Fernandes Araújo, Adriele da Silva Almeida, Ayla das Chagas Coimbra, Elaine S. de Souza, Marcus Vinícius Nora |
description | Purpose
Due to serious problems with the treatment of leishmaniasis all around the world, here is an urgent need in the search for new drugs that are more effective and safer for the treatment of the various forms of leishmaniasis. Actual therapy is limited and lacks sufficient efficacy due to incomplete elimination of the parasites form of patients. In this sense, we decided to evaluate, by first-time, a series of seventeen camphor hydrazone derivatives (2a–2p) against
Leishmania amazonensis
.
Methods
The compounds previously synthesized from camphor, an abundant natural compound, were evaluated in vitro against the extra and intracellular forms of
Leishmania amazonensis
, and murine macrophages.
Results
The majority of compounds, fourteen, displayed activity against the intracellular form of the parasite (amastigote) with IC
50
values ranging from 21.78 to 58.23 µM, being six compounds active for both forms of the parasite. The compound 2i exhibited higher activity against the amastigote form with the value of IC
50
(21.78 µM) close to standard utilized miltefosine (12.74 µM) and selectivity index of at least 6.9. Six compounds displayed activity against promastigote form of
Leishmania amazonensis
2g, 2j–2n (41.17–69.59 µM), with the compound 2m being the more active with IC
50
= 41.17 µM, 1.9 times less active than the reference drug (IC
50
= 21.39 µM). The compound 2m was the more selective to this form, with a selectivity index of at least 3.6. All the compounds were non-cytotoxic to macrophages.
Conclusions
Most compounds showed activity against amastigote form of
Leishmania amazonensis,
being that they were not cytotoxic to macrophage at the maximum tested concentration, showing the selective property of these compounds. Since amastigotes are the parasite stages that cause the disease in humans, these results highlight the antileishmanial effect of the compounds. This study indicates the possible development of candidates to leishmanicidal drugs from an abundant natural compound of easy access. |
doi_str_mv | 10.2478/s11686-019-00146-5 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2383815595</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2383815595</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-c46a1a94a4acd2fe5b0d1bceb38cc07eeb9a96e5b909bbb8aab8989094e6c56e3</originalsourceid><addsrcrecordid>eNp9kMtKAzEUhoMo3l_AhQRcj-YykybLUq9QcKPrcDI9bac4mZozLejTm7ZedkIgt-__D3yMXUhxrcqBvSEpjTWFkK4QQpamqPbYsbTOFNJWcj-flRaFskoesROihRClsdYesiMtrVZOyWPmnyJfN33q-JAIiVqMPe-mfATtct4l_vgxSfDZReS3mJo19M0aiUNekQ9nG3g4gyZSz8fY0LyF2ACHdhuJ1NAZO5jCG-H5937KXu_vXkaPxfj54Wk0HBe1HlR9UZcGJLgSSqgnaopVEBMZagza1rUYIAYHzuRnJ1wIwQIE62y-lGjqyqA-ZVe73mXq3ldIvV90qxTzSK-01VZWlasypXZUnTqihFO_TE0L6cNL4TdO_c6pz0791qnfhC6_q1ehxclv5EdiBvQOoPwVZ5j-Zv9T-wVr84Om</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2383815595</pqid></control><display><type>article</type><title>In vitro Assessment of Camphor Hydrazone Derivatives as an Agent Against Leishmania amazonensis</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>da Silva, Emerson Teixeira ; de Andrade, Gabriel Fernandes ; Araújo, Adriele da Silva ; Almeida, Ayla das Chagas ; Coimbra, Elaine S. ; de Souza, Marcus Vinícius Nora</creator><creatorcontrib>da Silva, Emerson Teixeira ; de Andrade, Gabriel Fernandes ; Araújo, Adriele da Silva ; Almeida, Ayla das Chagas ; Coimbra, Elaine S. ; de Souza, Marcus Vinícius Nora</creatorcontrib><description>Purpose
Due to serious problems with the treatment of leishmaniasis all around the world, here is an urgent need in the search for new drugs that are more effective and safer for the treatment of the various forms of leishmaniasis. Actual therapy is limited and lacks sufficient efficacy due to incomplete elimination of the parasites form of patients. In this sense, we decided to evaluate, by first-time, a series of seventeen camphor hydrazone derivatives (2a–2p) against
Leishmania amazonensis
.
Methods
The compounds previously synthesized from camphor, an abundant natural compound, were evaluated in vitro against the extra and intracellular forms of
Leishmania amazonensis
, and murine macrophages.
Results
The majority of compounds, fourteen, displayed activity against the intracellular form of the parasite (amastigote) with IC
50
values ranging from 21.78 to 58.23 µM, being six compounds active for both forms of the parasite. The compound 2i exhibited higher activity against the amastigote form with the value of IC
50
(21.78 µM) close to standard utilized miltefosine (12.74 µM) and selectivity index of at least 6.9. Six compounds displayed activity against promastigote form of
Leishmania amazonensis
2g, 2j–2n (41.17–69.59 µM), with the compound 2m being the more active with IC
50
= 41.17 µM, 1.9 times less active than the reference drug (IC
50
= 21.39 µM). The compound 2m was the more selective to this form, with a selectivity index of at least 3.6. All the compounds were non-cytotoxic to macrophages.
Conclusions
Most compounds showed activity against amastigote form of
Leishmania amazonensis,
being that they were not cytotoxic to macrophage at the maximum tested concentration, showing the selective property of these compounds. Since amastigotes are the parasite stages that cause the disease in humans, these results highlight the antileishmanial effect of the compounds. This study indicates the possible development of candidates to leishmanicidal drugs from an abundant natural compound of easy access.</description><identifier>ISSN: 1230-2821</identifier><identifier>EISSN: 1896-1851</identifier><identifier>DOI: 10.2478/s11686-019-00146-5</identifier><identifier>PMID: 31832921</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Amastigotes ; Animal Systematics/Taxonomy/Biogeography ; Animals ; Biomedical and Life Sciences ; Biomedicine ; Camphor ; Camphor - chemistry ; Camphor - pharmacology ; Cytotoxicity ; Derivatives ; Drug development ; Drug Discovery ; Drugs ; Ecology ; Evaluation ; Female ; Hydrazones ; Hydrazones - chemical synthesis ; Hydrazones - pharmacology ; Inhibitory Concentration 50 ; Intracellular ; Leishmania amazonensis ; Leishmania mexicana - drug effects ; Leishmania mexicana - growth & development ; Leishmaniasis ; Life Cycle Stages ; Macrophages ; Macrophages - drug effects ; Macrophages - parasitology ; Medical Microbiology ; Mice ; Mice, Inbred BALB C ; Microbiology ; Miltefosine ; Original Paper ; Parasites ; Parasitic diseases ; Parasitology ; Selectivity ; Vector-borne diseases</subject><ispartof>Acta parasitologica, 2020-03, Vol.65 (1), p.203-207</ispartof><rights>Witold Stefański Institute of Parasitology, Polish Academy of Sciences 2019</rights><rights>Witold Stefański Institute of Parasitology, Polish Academy of Sciences 2019.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-c46a1a94a4acd2fe5b0d1bceb38cc07eeb9a96e5b909bbb8aab8989094e6c56e3</citedby><cites>FETCH-LOGICAL-c375t-c46a1a94a4acd2fe5b0d1bceb38cc07eeb9a96e5b909bbb8aab8989094e6c56e3</cites><orcidid>0000-0003-1566-8110</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.2478/s11686-019-00146-5$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.2478/s11686-019-00146-5$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31832921$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>da Silva, Emerson Teixeira</creatorcontrib><creatorcontrib>de Andrade, Gabriel Fernandes</creatorcontrib><creatorcontrib>Araújo, Adriele da Silva</creatorcontrib><creatorcontrib>Almeida, Ayla das Chagas</creatorcontrib><creatorcontrib>Coimbra, Elaine S.</creatorcontrib><creatorcontrib>de Souza, Marcus Vinícius Nora</creatorcontrib><title>In vitro Assessment of Camphor Hydrazone Derivatives as an Agent Against Leishmania amazonensis</title><title>Acta parasitologica</title><addtitle>Acta Parasit</addtitle><addtitle>Acta Parasitol</addtitle><description>Purpose
Due to serious problems with the treatment of leishmaniasis all around the world, here is an urgent need in the search for new drugs that are more effective and safer for the treatment of the various forms of leishmaniasis. Actual therapy is limited and lacks sufficient efficacy due to incomplete elimination of the parasites form of patients. In this sense, we decided to evaluate, by first-time, a series of seventeen camphor hydrazone derivatives (2a–2p) against
Leishmania amazonensis
.
Methods
The compounds previously synthesized from camphor, an abundant natural compound, were evaluated in vitro against the extra and intracellular forms of
Leishmania amazonensis
, and murine macrophages.
Results
The majority of compounds, fourteen, displayed activity against the intracellular form of the parasite (amastigote) with IC
50
values ranging from 21.78 to 58.23 µM, being six compounds active for both forms of the parasite. The compound 2i exhibited higher activity against the amastigote form with the value of IC
50
(21.78 µM) close to standard utilized miltefosine (12.74 µM) and selectivity index of at least 6.9. Six compounds displayed activity against promastigote form of
Leishmania amazonensis
2g, 2j–2n (41.17–69.59 µM), with the compound 2m being the more active with IC
50
= 41.17 µM, 1.9 times less active than the reference drug (IC
50
= 21.39 µM). The compound 2m was the more selective to this form, with a selectivity index of at least 3.6. All the compounds were non-cytotoxic to macrophages.
Conclusions
Most compounds showed activity against amastigote form of
Leishmania amazonensis,
being that they were not cytotoxic to macrophage at the maximum tested concentration, showing the selective property of these compounds. Since amastigotes are the parasite stages that cause the disease in humans, these results highlight the antileishmanial effect of the compounds. This study indicates the possible development of candidates to leishmanicidal drugs from an abundant natural compound of easy access.</description><subject>Amastigotes</subject><subject>Animal Systematics/Taxonomy/Biogeography</subject><subject>Animals</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Camphor</subject><subject>Camphor - chemistry</subject><subject>Camphor - pharmacology</subject><subject>Cytotoxicity</subject><subject>Derivatives</subject><subject>Drug development</subject><subject>Drug Discovery</subject><subject>Drugs</subject><subject>Ecology</subject><subject>Evaluation</subject><subject>Female</subject><subject>Hydrazones</subject><subject>Hydrazones - chemical synthesis</subject><subject>Hydrazones - pharmacology</subject><subject>Inhibitory Concentration 50</subject><subject>Intracellular</subject><subject>Leishmania amazonensis</subject><subject>Leishmania mexicana - drug effects</subject><subject>Leishmania mexicana - growth & development</subject><subject>Leishmaniasis</subject><subject>Life Cycle Stages</subject><subject>Macrophages</subject><subject>Macrophages - drug effects</subject><subject>Macrophages - parasitology</subject><subject>Medical Microbiology</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Microbiology</subject><subject>Miltefosine</subject><subject>Original Paper</subject><subject>Parasites</subject><subject>Parasitic diseases</subject><subject>Parasitology</subject><subject>Selectivity</subject><subject>Vector-borne diseases</subject><issn>1230-2821</issn><issn>1896-1851</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtKAzEUhoMo3l_AhQRcj-YykybLUq9QcKPrcDI9bac4mZozLejTm7ZedkIgt-__D3yMXUhxrcqBvSEpjTWFkK4QQpamqPbYsbTOFNJWcj-flRaFskoesROihRClsdYesiMtrVZOyWPmnyJfN33q-JAIiVqMPe-mfATtct4l_vgxSfDZReS3mJo19M0aiUNekQ9nG3g4gyZSz8fY0LyF2ACHdhuJ1NAZO5jCG-H5937KXu_vXkaPxfj54Wk0HBe1HlR9UZcGJLgSSqgnaopVEBMZagza1rUYIAYHzuRnJ1wIwQIE62y-lGjqyqA-ZVe73mXq3ldIvV90qxTzSK-01VZWlasypXZUnTqihFO_TE0L6cNL4TdO_c6pz0791qnfhC6_q1ehxclv5EdiBvQOoPwVZ5j-Zv9T-wVr84Om</recordid><startdate>20200301</startdate><enddate>20200301</enddate><creator>da Silva, Emerson Teixeira</creator><creator>de Andrade, Gabriel Fernandes</creator><creator>Araújo, Adriele da Silva</creator><creator>Almeida, Ayla das Chagas</creator><creator>Coimbra, Elaine S.</creator><creator>de Souza, Marcus Vinícius Nora</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QL</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><orcidid>https://orcid.org/0000-0003-1566-8110</orcidid></search><sort><creationdate>20200301</creationdate><title>In vitro Assessment of Camphor Hydrazone Derivatives as an Agent Against Leishmania amazonensis</title><author>da Silva, Emerson Teixeira ; de Andrade, Gabriel Fernandes ; Araújo, Adriele da Silva ; Almeida, Ayla das Chagas ; Coimbra, Elaine S. ; de Souza, Marcus Vinícius Nora</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-c46a1a94a4acd2fe5b0d1bceb38cc07eeb9a96e5b909bbb8aab8989094e6c56e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Amastigotes</topic><topic>Animal Systematics/Taxonomy/Biogeography</topic><topic>Animals</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Camphor</topic><topic>Camphor - chemistry</topic><topic>Camphor - pharmacology</topic><topic>Cytotoxicity</topic><topic>Derivatives</topic><topic>Drug development</topic><topic>Drug Discovery</topic><topic>Drugs</topic><topic>Ecology</topic><topic>Evaluation</topic><topic>Female</topic><topic>Hydrazones</topic><topic>Hydrazones - chemical synthesis</topic><topic>Hydrazones - pharmacology</topic><topic>Inhibitory Concentration 50</topic><topic>Intracellular</topic><topic>Leishmania amazonensis</topic><topic>Leishmania mexicana - drug effects</topic><topic>Leishmania mexicana - growth & development</topic><topic>Leishmaniasis</topic><topic>Life Cycle Stages</topic><topic>Macrophages</topic><topic>Macrophages - drug effects</topic><topic>Macrophages - parasitology</topic><topic>Medical Microbiology</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Microbiology</topic><topic>Miltefosine</topic><topic>Original Paper</topic><topic>Parasites</topic><topic>Parasitic diseases</topic><topic>Parasitology</topic><topic>Selectivity</topic><topic>Vector-borne diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>da Silva, Emerson Teixeira</creatorcontrib><creatorcontrib>de Andrade, Gabriel Fernandes</creatorcontrib><creatorcontrib>Araújo, Adriele da Silva</creatorcontrib><creatorcontrib>Almeida, Ayla das Chagas</creatorcontrib><creatorcontrib>Coimbra, Elaine S.</creatorcontrib><creatorcontrib>de Souza, Marcus Vinícius Nora</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Acta parasitologica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>da Silva, Emerson Teixeira</au><au>de Andrade, Gabriel Fernandes</au><au>Araújo, Adriele da Silva</au><au>Almeida, Ayla das Chagas</au><au>Coimbra, Elaine S.</au><au>de Souza, Marcus Vinícius Nora</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vitro Assessment of Camphor Hydrazone Derivatives as an Agent Against Leishmania amazonensis</atitle><jtitle>Acta parasitologica</jtitle><stitle>Acta Parasit</stitle><addtitle>Acta Parasitol</addtitle><date>2020-03-01</date><risdate>2020</risdate><volume>65</volume><issue>1</issue><spage>203</spage><epage>207</epage><pages>203-207</pages><issn>1230-2821</issn><eissn>1896-1851</eissn><abstract>Purpose
Due to serious problems with the treatment of leishmaniasis all around the world, here is an urgent need in the search for new drugs that are more effective and safer for the treatment of the various forms of leishmaniasis. Actual therapy is limited and lacks sufficient efficacy due to incomplete elimination of the parasites form of patients. In this sense, we decided to evaluate, by first-time, a series of seventeen camphor hydrazone derivatives (2a–2p) against
Leishmania amazonensis
.
Methods
The compounds previously synthesized from camphor, an abundant natural compound, were evaluated in vitro against the extra and intracellular forms of
Leishmania amazonensis
, and murine macrophages.
Results
The majority of compounds, fourteen, displayed activity against the intracellular form of the parasite (amastigote) with IC
50
values ranging from 21.78 to 58.23 µM, being six compounds active for both forms of the parasite. The compound 2i exhibited higher activity against the amastigote form with the value of IC
50
(21.78 µM) close to standard utilized miltefosine (12.74 µM) and selectivity index of at least 6.9. Six compounds displayed activity against promastigote form of
Leishmania amazonensis
2g, 2j–2n (41.17–69.59 µM), with the compound 2m being the more active with IC
50
= 41.17 µM, 1.9 times less active than the reference drug (IC
50
= 21.39 µM). The compound 2m was the more selective to this form, with a selectivity index of at least 3.6. All the compounds were non-cytotoxic to macrophages.
Conclusions
Most compounds showed activity against amastigote form of
Leishmania amazonensis,
being that they were not cytotoxic to macrophage at the maximum tested concentration, showing the selective property of these compounds. Since amastigotes are the parasite stages that cause the disease in humans, these results highlight the antileishmanial effect of the compounds. This study indicates the possible development of candidates to leishmanicidal drugs from an abundant natural compound of easy access.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>31832921</pmid><doi>10.2478/s11686-019-00146-5</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0003-1566-8110</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1230-2821 |
ispartof | Acta parasitologica, 2020-03, Vol.65 (1), p.203-207 |
issn | 1230-2821 1896-1851 |
language | eng |
recordid | cdi_proquest_journals_2383815595 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Amastigotes Animal Systematics/Taxonomy/Biogeography Animals Biomedical and Life Sciences Biomedicine Camphor Camphor - chemistry Camphor - pharmacology Cytotoxicity Derivatives Drug development Drug Discovery Drugs Ecology Evaluation Female Hydrazones Hydrazones - chemical synthesis Hydrazones - pharmacology Inhibitory Concentration 50 Intracellular Leishmania amazonensis Leishmania mexicana - drug effects Leishmania mexicana - growth & development Leishmaniasis Life Cycle Stages Macrophages Macrophages - drug effects Macrophages - parasitology Medical Microbiology Mice Mice, Inbred BALB C Microbiology Miltefosine Original Paper Parasites Parasitic diseases Parasitology Selectivity Vector-borne diseases |
title | In vitro Assessment of Camphor Hydrazone Derivatives as an Agent Against Leishmania amazonensis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T15%3A52%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vitro%20Assessment%20of%20Camphor%20Hydrazone%20Derivatives%20as%20an%20Agent%20Against%20Leishmania%20amazonensis&rft.jtitle=Acta%20parasitologica&rft.au=da%20Silva,%20Emerson%20Teixeira&rft.date=2020-03-01&rft.volume=65&rft.issue=1&rft.spage=203&rft.epage=207&rft.pages=203-207&rft.issn=1230-2821&rft.eissn=1896-1851&rft_id=info:doi/10.2478/s11686-019-00146-5&rft_dat=%3Cproquest_cross%3E2383815595%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2383815595&rft_id=info:pmid/31832921&rfr_iscdi=true |